Predictors of acute kidney injury associated with intravenous colistin treatment.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  International Journal of Antimicrobial Agents

• Publication date

  2010-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijantimicag.2009.12.002PMID 20089383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatorenal syndrome: the 8th international consensus conference of the Acute Dialysis Quality Initiative (ADQI) Group

  2012cited by this paper
• Prevalence and Risk Factors for Aminoglycoside Nephrotoxicity in Intensive Care Units

  2009cited by this paper
• Nephrotoxicity associated with intravenous colistin (colistimethate sodium) treatment at a tertiary care medical center.

  2009influential reference
• Clinical characteristics and risk factors of colistin-induced nephrotoxicity.

  2009cited by this paper
• Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance

  2008cited by this paper
• The RIFLE criteria and mortality in acute kidney injury: A systematic review.

  2008cited by this paper
• Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.

  2008cited by this paper
• Safety and efficacy of colistin compared with imipenem in the treatmentof ventilator-associated pneumonia: a matched case–control study

  2007cited by this paper
• Incidence and outcomes in acute kidney injury: a comprehensive population-based study.

  2007cited by this paper
• The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited.

  2006cited by this paper
• Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria

  2006cited by this paper
• Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.

  2006cited by this paper
• Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.

  2005influential reference
• Nephrotoxicity of intravenous colistin: a prospective evaluation.

  2005influential reference
• Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.

  2005influential reference
• Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.

  2005influential reference
• Hyperuricemia and hypoalbuminemia predispose to cisplatin-induced nephrotoxicity

  2004cited by this paper
• Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

  2004cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Increasing threat of Gram-negative bacteria

  2001cited by this paper
• Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.

  1999cited by this paper
• Renal dysfunction in obstructive jaundice

  1995cited by this paper
• Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties.

  1995cited by this paper
• Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles.

  1993cited by this paper
• Aminoglycoside nephrotoxicity in obstructive jaundice.

  1988cited by this paper
• Aminoglycoside nephrotoxicity.

  1988cited by this paper

• Diagnostic Accuracy of Albumin Levels in Predicting Colistin-Induced Nephrotoxicity in Critically ill Patients in the Intensive Care Unit

  2025cites this paper
• Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic Strategies

  2025cites this paper
• Genetic predisposition and high exposure to colistin in the early treatment period as independent risk factors for colistin‐induced nephrotoxicity

  2024cites this paper
• Abrupt increased serum creatinine in a hyperferritinemia patient treated with deferoxamine after cord blood transplantation: a case report with literature review

  2023cites this paper
• Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment

  2023cites this paper
• Lipopolysaccharide as an antibiotic target.

  2023cites this paper
• Mortality due to carbapenemase‐producing GNB in transplantation: Are risk scores useful?

  2023cites this paper
• Development of a Prediction Model for Acute Kidney Injury after Colistin Treatment for Multidrug-resistant Acinetobacter baumanii Ventilator-Associated Pneumonia: A Pilot Study

  2022cites this paper
• Antibiotic resistance pattern of Klebsiella pneumoniae a major problem for society

  2022cites this paper
• Colistin Nephrotoxicity-Age and Baseline kidney Functions Hold the Key

  2021cites this paper
• Characteristics, Influencing Factors, Predictive Scoring System, and Outcomes of the Patients with Nephrotoxicity Associated with Administration of Intravenous Colistin

  2021cites this paper
• Colistimethate Sodium Dosing and Nephrotoxicity among in-Patients at Tertiary Care Hospital Karachi, Pakistan

  2021cites this paper
• Evaluation of mortality and acute kidney injury by KDIGO and RIFLE in patients treated with colistin in the intensive care unit

  2021cites this paper
• Acute Kidney Injury related to intravenous Colistin Use in Lebanese Hospitalized Patients: Incidence and Associated Factors.

  2021cites this paper
• Kolistin ve Böbrek Yetmezliği İlişkisi: Tek Merkez Deneyimi

  2021cites this paper
• Low albumin levels are independently associated with neonatal acute kidney injury: a report from AWAKEN Study Group

  2021cites this paper
• Comparisons of Colistin-Induced Nephrotoxicity Between Two Different Formulations of Colistin in Critically Ill Patients: A Retrospective Cohort Study

  2021cites this paper
• Acquired Bartter-like Syndrome Presenting with Polyuria and Reversible Hypokalemia Associated with Colistin Use in a Critically Ill Pediatric Patient

  2021cites this paper
• A single-centered study of factors affecting colistin related nephropathy

  2020cites this paper
• Systematic review on estimated rates of nephrotoxicity and neurotoxicity in patients treated with polymyxins.

  2020cites this paper
• Polymyxin-induced nephrotoxicity and its predictors: a systematic review and meta-analysis of studies conducted using RIFLE criteria of acute kidney injury.

  2020cites this paper
• Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli.

  2020cites this paper
• Colistina en el tratamiento de infecciones por pseudomonas aeruginosa y acinetobacter baumannii extensivamente resistentes (XDR) en un hospital de tercer nivel

  2020cites this paper
• A Comparative Study of High-Dose Colistin Administration for the Management of Multidrug-Resistant Gram-Negative Infections in the ICU

  2020cites this paper
• Impact of Colistin Dosing on the Incidence of Nephrotoxicity in a Tertiary Care Hospital in Saudi Arabia

  2020cites this paper
• Acute kidney injury following colistin treatment in critically-ill patients: may glucocorticoids protect?

  2020cites this paper
• Colistimethate sodium and acute kidney injury: Incidence, risk factors, outcome and prognosis of renal function.

  2020cites this paper
• Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity

  2019cites this paper
• Does nephrotoxicity develop less frequently when vancomycin is combined with imipenem-cilastatin than with meropenem? A comparative study

  2019cites this paper
• Incidence and Risk Factors of Acute Kidney Failure in Patients Receiving Colistin in a Provincial Hospital

  2019influential citation
• Colistin Resistance in Enterobacterales Strains – A Current View

  2019cites this paper
• Miscellaneous antibacterial drugs

  2019cites this paper
• Treatment Options for Colistin Resistant Klebsiella pneumoniae: Present and Future

  2019cites this paper
• Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy.

  2019cites this paper
• Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies.

  2019cites this paper
• Can octapeptin antibiotics combat extensively drug-resistant (XDR) bacteria?

  2018cites this paper
• Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium

  2018influential citation
• Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment

  2018cites this paper
• Neutrophil Gelatinase-associated Lipocalin as a Predictor of Acute Kidney Injury in Patients during Treatment with Colistimethate Sodium

  2018cites this paper
• Antimicrobial resistance and treatment: an unmet clinical safety need

  2018cites this paper
• Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.

  2018cites this paper
• Colistin nephrotoxicity in the ICU: Is it different in the geriatric patients?

  2018cites this paper
• The challenge of urinary tract infections in renal transplant recipients

  2018cites this paper
• Carbapenem‐resistant Klebsiella pneumoniae vertebral osteomyelitis in a renal transplant recipient treated with ceftazidime‐avibactam

  2018cites this paper
• Prolonged Intravenous Colistin Use Associated with Acquired Bartter-Like Syndrome in an Adult Patient: A Case Report

  2018cites this paper
• Recent advances and perspectives in the design and development of polymyxins.

  2017cites this paper
• Causal relationship between hypoalbuminemia and acute kidney injury

  2017cites this paper
• Methionine Ameliorates Polymyxin-Induced Nephrotoxicity by Attenuating Cellular Oxidative Stress

  2017cites this paper
• Individual and Combined Effects of Engineered Peptides and Antibiotics on Pseudomonas aeruginosa Biofilms

  2017cites this paper
• Genetic Variants Contributing to Colistin Cytotoxicity: Identification of TGIF1 and HOXD10 Using a Population Genomics Approach

  2017cites this paper
• Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies

  2017cites this paper
• Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria

  2017cites this paper
• Evaluation of Renal Toxicity of Colistin Therapy With Neutrophil Gelatinase-associated Lipocalin: a Biomarker of Renal Tubular Damage.

  2017cites this paper
• In vitro efficacy of synergistic antibiotic combinations in imipenem resistant Pseudomonas aeruginosa strains

  2017cites this paper
• Resistance to Colistin in Klebsiella Pneumoniae: A 4.0 Strain?

  2017cites this paper
• Good tolerability of high dose colistin-based therapy in patients with haematological malignancies

  2017cites this paper
• Polymyxin Pharmacokinetics and Pharmacodynamics

  2016cites this paper
• Variables determining the development of colistin-associated renal impairment

  2016cites this paper
• Risk factors of multidrug-resistant Acinetobacter baumannii recurrence after successful eradication in ventilated patients

  2016cites this paper
• Septic shock is an independent risk factor for colistin-induced severe acute kidney injury: a retrospective cohort study

  2016cites this paper
• Treatment of Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia: Retrospective Comparison Between Intravenous Colistin and Intravenous Ampicillin–Sulbactam

  2016cites this paper
• Is high-dose β-lactam therapy associated with excessive drug toxicity in critically ill patients?

  2016cites this paper
• Colistin efficacy in the treatment of multidrug-resistant and extremelydrug-resistant gram-negative bacterial infections.

  2016cites this paper
• Characterization of urinary metabolites as biomarkers of colistin-induced nephrotoxicity in rats by a liquid chromatography/mass spectrometry-based metabolomics approach.

  2016cites this paper
• Evaluation of Risk Factors for Intravenous Colistin Use-related Nephrotoxicity.

  2016cites this paper
• Antibiotic Dosing in Patients With Acute Kidney Injury

  2016cites this paper
• Risk Factors for Colistin-Associated Acute Kidney Injury: A Multicenter Study from Turkey.

  2016cites this paper
• ESTABLISHMENT AND COMPARISON OF NEPHROTOXICITY ASSOCIATEDWITH THE USE OF VARIOUS DOSES OF COLISTIN IN RABBITS

  2016cites this paper
• Clinical outcomes and safety of colistin in treatment of gram negative infections: A prospective observational study

  2016cites this paper
• Optimising use of fosfomycin against multidrug-resistant Pseudomonas aeruginosa

  2016cites this paper
• Urinary Tract Infections and Surgical Site Infections due to Carbapenem-Resistant Enterobacteriaceae in Renal Transplant.

  2016cites this paper
• Acinetobacter spp in Intensive Care Unit: Risk Factors Associated with Infection and Fatality

  2016cites this paper
• Strategies for the safe use of colistin

  2015cites this paper
• Epidemiology and outcomes of carbapenem‐resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients

  2015cites this paper
• Adverse Reactions Associated with Systemic Polymyxin Therapy

  2015cites this paper
• Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study.

  2015cites this paper
• Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistance.

  2015cites this paper
• Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.

  2015cites this paper
• Association Between Colistin Dose and Development of Nephrotoxicity*

  2015cites this paper
• The safety of polymyxin antibiotics

  2015influential citation
• Polymyxin Combinations against Pseudomonas aeruginosa : Profiling the Time-Course of Synergistic Killing and Prevention of Resistance

  2015cites this paper
• High dose intravenous colistin methanesulfonate therapy is associated with high rates of nephrotoxicity; a prospective cohort study from Saudi Arabia

  2015influential citation
• A review on colistin nephrotoxicity

  2015cites this paper
• Colistin: efficacy and safety in different populations

  2015influential citation
• Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.

  2014cites this paper
• Update on colistin in clinical practice.

  2014cites this paper
• Colistin- and Polymyxin-Induced Nephrotoxicity

  2014influential citation
• Scheme of Acute Kidney Injury Colistin-and Polymyxin-Induced Nephrotoxicity : Focus on Literature Utilizing the RIFLE Classification

  2014influential citation
• Pharmacokinetics and Pharmacodynamics of Colistin

  2014cites this paper
• Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.

  2014cites this paper
• Colistin nephrotoxicity increases with age

  2014cites this paper
• Validation of a Model To Predict the Risk of Nephrotoxicity in Patients Receiving Colistin

  2014cites this paper
• Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management

  2014cites this paper
• Emergent Renal Dysfunction with Colistin Pharmacotherapy

  2013cites this paper
• N-acetylcysteine for the prevention of non-contrast media agent-induced kidney injury: from preclinical data to clinical evidence

  2013cites this paper
• Cell cycle arrest in a model of colistin nephrotoxicity.

  2013cites this paper
• Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes.

  2013cites this paper
• Synergistic Activity of Colistin and Rifampin Combination against Multidrug-Resistant Acinetobacter baumannii in an In Vitro Pharmacokinetic/Pharmacodynamic Model

  2013cites this paper
• CALL FOR PAPERS Understanding the Mechanisms of Disease Using Biomarkers Cell cycle arrest in a model of colistin nephrotoxicity

  2013cites this paper
• Incidence and Predictors of Nephrotoxicity Associated with Intravenous Colistin in Overweight and Obese Patients

  2012cites this paper